The unique process enhances a balance of specific peptides formulated to maximize the Glutathione producing benefits
Type 2 Diabetes: Significantly reduce glycated hemoglobin (HbA1c) and improve blood sugar control
Eligible studies included randomized controlled trials (RCTs) with at least 3,000 participants and a minimum follow-up duration of 12 months
To date, these GLP-1 drugs have been approved to treat three adult populations: individuals with type 2 diabetes, individuals with a body mass index (BMI) of 30 or greater (obesity), and individuals with a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain (angina)
2022 Aug 13;58(8)
Somatotroph Cells Cells in the anterior pituitary gland that produce and secrete growth hormone